Evidence map›Paper›PMID 41590347›Full record

SynthesisCurrent oncology (Toronto, Ont.)2026

Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Platinum-Based Delayed-Phase Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis.

Wenlin Gong, Hongxin Qie, Yuxiang Xu, Peiyuan Wang, Jinglin Gao, Mingxia Wang

Abstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenlin GongDepartment of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050010, China.ORCID 0009-0001-6997-7122
Hongxin QieDepartment of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050010, China.
Yuxiang XuDepartment of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050010, China.
Peiyuan WangDepartment of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050010, China.
Jinglin GaoDepartment of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050010, China.
Mingxia WangDepartment of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050010, China.

Funding

Hebei Science and Technology Major Project for Biological Medicine Innovation and Development No. 23377707D
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntiemeticsAntineoplastic AgentsNauseaOlanzapineVomitingHumansAntiemeticsAntineoplastic AgentsOlanzapinechemotherapyCINVcomplete responsenauseaolanzapineplatinum-based

Identifiers

PMID41590347
PMCPMC12840039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.